GI
IRON icon

GAMMA Investing’s Disc Medicine IRON Stock Holding History

GAMMA Investing’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$22.6K Buy
346
+54
+18% +$4.08K ﹤0.01% 2872
2026
Q2 		$21.4K Buy
292
+24
+9% +$1.65K ﹤0.01% 2806
2026
Q1 		$17.1K Sell
268
-36
-12% -$2.5K ﹤0.01% 2803
2025
Q4 		$24.1K Buy
304
+28
+10% +$2.37K ﹤0.01% 2504
2025
Q3 		$18.2K Buy
276
+36
+15% +$2.14K ﹤0.01% 2561
2025
Q2 		$12.7K Sell
240
-10
-4% -$470 ﹤0.01% 2685
2025
Q1 		$12.4K Buy
250
+11
+5% +$612 ﹤0.01% 2641
2024
Q4 		$15.2K Buy
239
+139
+139% +$8.04K ﹤0.01% 2406
2024
Q3 		$4.91K Buy
100
+79
+376% +$3.71K ﹤0.01% 2750
2024
Q2 		$946 Buy
21
+11
+110% +$374 ﹤0.01% 3073
2024
Q1 		$623 Buy
+10
New +$648 ﹤0.01% 3060

Other funds holding IRON

VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's IRON Position: Q3 2026 in Review

GAMMA Investing increased its Disc Medicine (IRON) stake by 18% in Q3 2026, buying an estimated $4.08K and bringing the position to 346 shares worth $22.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2872.

GAMMA Investing first reported a position in IRON in Q1 2024 and has held it in 11 quarters since. The position peaked at $24.1K in Q4 2025. 3 funds tracked by Wall St. Rank hold IRON as of Q3 2026.

  • GAMMA Investing held 346 shares of Disc Medicine worth $22.6K as of Q3 2026.
  • GAMMA Investing bought 54 Disc Medicine shares in Q3 2026, an estimated $4.08K.
  • Disc Medicine made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2872 holding.
  • GAMMA Investing first reported a position in Disc Medicine in Q1 2024 and has held it in 11 quarters since.
  • GAMMA Investing's Disc Medicine position peaked at $24.1K in Q4 2025.
  • 3 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.